Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

PFS affects some women, steroids easily bought online, hypogonadism info unreliable, low testosterone linked to CVD.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride for hair loss doesn't harm erectile function; weight loss and exercise improve it.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Finasteride for female hair loss has low side effects, more research needed.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Left-handed men experience more sexual side effects from finasteride treatment.

Finasteride can cause sexual problems and depression in young men.

Metabolic syndrome reduces effectiveness of hair loss treatment.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Technology can improve sexual dysfunction in chronic disease patients but faces challenges like cost and accessibility.